These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23928990)

  • 21. miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer.
    Kim YS; Park SJ; Lee YS; Kong HK; Park JH
    Oncotarget; 2016 Jul; 7(27):42261-42273. PubMed ID: 27304060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
    Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L
    FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
    Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
    Li Y; Meeran SM; Patel SN; Chen H; Hardy TM; Tollefsbol TO
    Mol Cancer; 2013 Feb; 12():9. PubMed ID: 23379261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer.
    Zhao JJ; Lin J; Yang H; Kong W; He L; Ma X; Coppola D; Cheng JQ
    J Biol Chem; 2008 Nov; 283(45):31079-86. PubMed ID: 18790736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.
    Ward A; Shukla K; Balwierz A; Soons Z; König R; Sahin O; Wiemann S
    J Pathol; 2014 Aug; 233(4):368-79. PubMed ID: 24752803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.
    Tolhurst RS; Thomas RS; Kyle FJ; Patel H; Periyasamy M; Photiou A; Thiruchelvam PT; Lai CF; Al-Sabbagh M; Fisher RA; Barry S; Crnogorac-Jurcevic T; Martin LA; Dowsett M; Charles Coombes R; Kamalati T; Ali S; Buluwela L
    Breast Cancer Res Treat; 2011 Jul; 128(2):357-68. PubMed ID: 20730598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.
    Cui J; Yang Y; Li H; Leng Y; Qian K; Huang Q; Zhang C; Lu Z; Chen J; Sun T; Wu R; Sun Y; Song H; Wei X; Jing P; Yang X; Zhang C
    Oncogene; 2015 Jul; 34(30):3895-907. PubMed ID: 25531331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-26a-5p inhibits breast cancer cell growth by suppressing RNF6 expression.
    Huang ZM; Ge HF; Yang CC; Cai Y; Chen Z; Tian WZ; Tao JL
    Kaohsiung J Med Sci; 2019 Aug; 35(8):467-473. PubMed ID: 31063232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.
    Andruska N; Zheng X; Yang X; Helferich WG; Shapiro DJ
    Oncogene; 2015 Jul; 34(29):3760-9. PubMed ID: 25263449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer.
    Ma H; Tian T; Liang S; Liu X; Shen H; Xia M; Liu X; Zhang W; Wang L; Chen S; Yu L
    Oncotarget; 2016 Mar; 7(9):10594-605. PubMed ID: 26871282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22.
    Li J; Lu M; Jin J; Lu X; Xu T; Jin S
    Cell Physiol Biochem; 2018; 50(1):136-149. PubMed ID: 30278449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.
    Jiang CF; Li DM; Shi ZM; Wang L; Liu MM; Ge X; Liu X; Qian YC; Wen YY; Zhen LL; Lin J; Liu LZ; Jiang BH
    Oncotarget; 2016 Jun; 7(24):36940-36955. PubMed ID: 27175587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.
    Di Leva G; Piovan C; Gasparini P; Ngankeu A; Taccioli C; Briskin D; Cheung DG; Bolon B; Anderlucci L; Alder H; Nuovo G; Li M; Iorio MV; Galasso M; Santhanam R; Marcucci G; Perrotti D; Powell KA; Bratasz A; Garofalo M; Nephew KP; Croce CM
    PLoS Genet; 2013; 9(3):e1003311. PubMed ID: 23505378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
    Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
    Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.
    Wang J; Yang K; Cao J; Li L
    Bioengineered; 2021 Dec; 12(2):10624-10637. PubMed ID: 34738502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
    Keeton EK; Brown M
    Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis.
    Chu HW; Cheng CW; Chou WC; Hu LY; Wang HW; Hsiung CN; Hsu HM; Wu PE; Hou MF; Shen CY; Yu JC
    Hum Mol Genet; 2014 Jan; 23(2):355-67. PubMed ID: 24009311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.